Press releases
The paper entitled ‘Role of RNA modifications in cancer’ is an authoritative and comprehensive review of the emerging and highly promising field of RNA epigenetics, highlighting pathways implicated in cancer to-date, describing their biological functions and their connections to the disease.
Read more
STORM Principal Scientists and collaborators develop novel algorithm for measuring RNA modifications by mass spectrometry
Read more
Konstantinos Tzelepis, PhD, presented award-winning abstract on METTL3
Read more
Data to be presented at inaugural STORM Therapeutics RNA Epigenetics in Human Disease Conference in Cambridge, UK
Read more
STORM Therapeutics, the drug discovery company focused on the discovery of small molecule therapeutics modulating RNA epigenetics, today announced that it will be hosting an international conference focused on the emerging field of “RNA epigenetics”.
Read more